2007年

Transcranial sonography of the substantia nigra in Japanese patients with Parkinson's disease or atypical parkinsonism: clinical potential and limitations.
Okawa M, Miwa H, Kajimoto Y, Hama K, Morita S, Nakanishi I, Kondo T.
Intern Med. 2007;46(18):1527-31.
Nutritional status and risk of amyotrophic lateral sclerosis in Japan.
Okamoto K, Kihira T, Kondo T, Kobashi G, Washio M, Sasaki S, Yokoyama T, Miyake Y, Sakamoto N, Inaba Y, Nagai M.
Amyotroph Lateral Scler. 2007 Oct;8(5):300-4.
[Drug induced dyskinesia].
Kondo T, Ishiguchi H.
Nihon Naika Gakkai Zasshi. 2007 Aug 10;96(8):1621-6.
Expression of insulin-like growth factor-II and leukemia inhibitory factor antibody immunostaining on the ionized calcium-binding adaptor molecule 1-positive microglias in the spinal cord of amyotrophic lateral sclerosis patients.
Kihira T, Suzuki A, Kubo T, Miwa H, Kondo T.
Neuropathology. 2007 Jun;27(3):257-68.
Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study.
Mizuno Y, Abe T, Hasegawa K, Kuno S, Kondo T, Yamamoto M, Nakashima M, Kanazawa I; STRONG Study Group.
Mov Disord. 2007 Oct 15;22(13):1860-5.
Effects of zonisamide on experimental tremors in rats.
Miwa H, Hama K, Kajimoto Y, Kondo T.
Parkinsonism Relat Disord. 2008;14(1):33-6
The role of exogenous risk factors in amyotrophic lateral sclerosis in Wakayama, Japan.
Kihira T, Kanno S, Miwa H, Okamoto K, Kondo T.
Amyotroph Lateral Scler. 2007 Jun;8(3):150-6.
p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.
Mogi M, Kondo T, Mizuno Y, Nagatsu T.
Neurosci Lett. 2007 Feb 27;414(1):94-7.
Placebo-controlled, double-blind dose-finding study of entacapone in fluctuating parkinsonian patients.
Mizuno Y, Kanazawa I, Kuno S, Yanagisawa N, Yamamoto M, Kondo T.
Mov Disord. 2007 Jan;22(1):75-80.
Drug discarding: a problematic therapeutic event in Parkinson's disease.
Miwa H, Hiwatani Y, Kondo T.
Mov Disord. 2007 Jan 15;22(2):293.

PAGE TOP

AltStyle によって変換されたページ (->オリジナル) /